The Benefit of the Doubt in GDMT

In the real world, it's totally different. There's all these increased likelihood of harm for 10 different reasons that weren't really present in the clinical trial. So I wouldn't want this to be a license to do. We're just going to study 1,000 patients, even though we need to study 5,000 patients. And whether physicians in practice start anticoagulation at two days or four days or six days or eight days doesn't really matter. Nobody is necessarily benefiting from like, there's no benefit to be gained from that.